Cerus corporation reports successful inactivation of sars-cov-2 with the intercept blood system for plasma

Cerus corporation (nasdaq:cers) announced today study results demonstrating that the intercept blood system inactivates sars-cov-2, the causative agen

DLHC Ratings Summary

DLHC Quant Ranking